Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin

Journal of Neural Transmission

Volumn 103, Issue 12, 1996, Pages 1397-1404

  Gudelsky, G A ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA); Ascorbic acid; Cysteine; Dopamine; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ASCORBIC ACID; CYSTEINE; DOPAMINE; FREE RADICAL; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG ACCUMULATION; MALE; MICRODIALYSIS; NEUROTOXICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANIMALS; ASCORBIC ACID; BRAIN; CYSTEINE; DOPAMINE; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

EID: 0030481579     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271253     Document Type: Article

References (34)

1. Battaglia G, Yeh SY, De Souza E (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29: 269-274
2. Brodkin JA, Malyala A, Nash JF (1993) Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 45: 647-653
3. Cadet JL, Ladenheim B, Baum I, Carlson E, Epstein C (1994a) CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetaine (MDMA). Brain Res 655: 259-262
4. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C (1994b) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismustase transgenic mice. J Neurochem 62: 380-383
5. Chiueh CC, Miyake H, Peng M-T (1993) Role of dopamine autoxidation, hydroyxl radical generation and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv Neurol 60: 251-258
6. Colado M, Green AR (1995) The spin trap agent alpha-phenyl-N-tert-butyl nitrone prevents "ecstasy"-induced neurodegeneration of 5-hydroxytryptamine neurons. Eur J Pharmacol 280: 343-346
7. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241: 338-345
8. De Vito M, Wagner GL (1989) Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology 28: 1145-1150
9. Filloux F, Townsend JJ (1993) Pre and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119: 79-88
10. Floyd RA, Watson JJ, Wong PK (1984) Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection phenol and salicylate hydroxylation products. J Biochem Biophys Methods 190: 221-235
11. Gibb JW, Johnson M, Hanson GR (1990) Neurochemical basis of neurotoxicity. Neurotoxicology 11: 317-322
12. Giovanni A, Liang L, Hastings TG, Zigmond M (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J Neurochem 64: 1819-1825
13. Gudelsky G, Yamamoto B (1994) MDMA increases the extracellular concentration of 2,3-dihydroxybenzoic acid in the striatum: evidence for increased hydroxyl radical formation. Soc Neuroci Abstr 20: 343
14. 2 agonists. Eur J Pharmacol 264: 325-330
15. Gutteridge J, Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 15: 129-135
16. 3H]dopamine: impact of ascorbic and glutathione. J Neurochem 63: 1126-1132
17. Hiramatsu M, Kumagai Y, Unger S, Cho A (1990) Metabolism of methylenedioxymethamphetmine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther 254: 521-528
18. Hirata H, Ladenheim B, Rothman R, Epstien C, Cadet JL (1995) Methampehtamine-induced serotoinin neurotoxicity is mediated by superoxide radicals. Brain Res 677: 345-347
19. Invernizzi R, Fracesso C, Caccia S, Di Clemente A, Garattini S, Samanin R (1989) Effect of L-cysteine on the long-term depletion of brain indoles caused by p-chloroamphetamine and d-fenfluramine in rats. Relation to brain drug concentrations. Eur J Pharmacol 163: 77-83
20. Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26: 428-435
21. Nash JF (1990) Ketanserin pretreatment blocks MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis. Life Sci 47: 2401-2408
22. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocyto-chemical evidence for neurotoxicity. J Neurosci 8: 2788-2803
23. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd ed. Academic Press, New York
24. Rosenberg PA (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci 8: 3887-2894
25. Scanzello CR, Hatzidimitriou G, Martello AL, Katz GL, Ricaurte GA (1993) Serotonergic recovery after (±) 3,4-(methylenedioxy)methamphetamine injury: observations in rats. J Pharmacol Exp Ther 264: 1484-1492
26. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240: 1-7
27. Schmidt CJ, Taylor VL, Abbate G, Nieduzak T (1991) 5-HT2 Antagonists stereoselectively prevent the neurotoxicity of 3,4-methlenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa. J Pharmacol Exp Ther 256: 230-235
28. Schmidt CJ, Sullivan CK, Fadayel GM (1994) Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. J Neurochem 62: 1382-1389
29. Sprague J, Nichols DE (1995) The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. J Pharmacol Exp Ther 273: 667-673
30. Steranka L, Rhind A (1987) Effect of cysteine on the persistent depletion of brain monoamines by amphetamine, p-chloroamphetamine and MPTP. Eur J Pharmacol 133: 191-197
31. Stone DM, Merchant KM, Hanson GR, Gibb JW (1987) Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacol 26: 1677-1683
32. Stone DM, Johnson M, Hanson GR, Gibb JW (1988) Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther 247: 79-87
33. Stone DM, Hanson GR, Gibb JW (1989) In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine. J Neurochem 53: 572-581
34. Wagner G, Carelli R, Jarvis M (1985) Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res Comm Chem Path Pharm 47: 221-228